We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
21.7
quarters
Top 10 Avg Time Held
6.6
quarters
Top 20 Avg Time Held
9.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1551
Remitly
RELY
$4.98B
| $131K | ﹤0.01% |
6,999
+6,976
| +30,330% | +$145K |
2023 Q1
9 quarters
|
|
1552
Qiagen
QGEN
$9.36B
| $130K | ﹤0.01% |
2,715
-1,024
| -27% | -$44.5K |
2025 Q1
1 quarter
|
|
1553
Bank of Hawaii
BOH
$2.65B
| $130K | ﹤0.01% |
+1,927
| New | +$128K |
2025 Q2
0 quarters
|
|
1554
Covista Inc
CVSA
$4.36B
| $129K | ﹤0.01% |
1,016
-120
| -11% | -$14.2K |
2024 Q2
4 quarters
|
|
1555
AMC Global Media
AMCX
$450M
| $127K | ﹤0.01% |
20,292
+11,493
| +131% | +$72.6K |
2013 Q2
48 quarters
|
|
1556
Acadia Realty Trust
AKR
$2.52B
| $127K | ﹤0.01% |
6,850
-7,848
| -53% | -$152K |
2023 Q2
8 quarters
|
|
1557
Descartes Systems
DSGX
$7.16B
| $127K | ﹤0.01% |
1,246
+254
| +26% | +$26.8K |
2023 Q3
7 quarters
|
|
1558
City Holding Co
CHCO
$1.97B
| $127K | ﹤0.01% |
1,034
| – | – |
2022 Q4
10 quarters
|
|
1559
Global Payments
GPN
$21.7B
| $126K | ﹤0.01% |
1,579
+83
| +6% | +$6.57K |
2013 Q2
48 quarters
|
|
1560
Royalty Pharma
RPRX
$25.7B
| $126K | ﹤0.01% |
3,500
| – | – |
2022 Q4
10 quarters
|
|
1561
Cohu
COHU
$3.09B
| $126K | ﹤0.01% |
6,548
+5,691
| +664% | +$96K |
2024 Q3
3 quarters
|
|
1562
DELISTED
Exact Sciences
EXAS
| $126K | ﹤0.01% |
+2,368
| New | +$120K |
2025 Q2
0 quarters
|
|
1563
W.R. Berkley
WRB
$27.1B
| $126K | ﹤0.01% |
1,709
-31
| -2% | -$2.22K |
2022 Q1
13 quarters
|
|
1564
DuPont de Nemours
DD
$17.5B
| $125K | ﹤0.01% |
1,451
-2,359
| -62% | -$196K |
2017 Q4
30 quarters
|
|
1565
Raymond James Financial
RJF
$30.5B
| $122K | ﹤0.01% |
794
-20
| -2% | -$2.86K |
2013 Q2
48 quarters
|
|
1566
Schrodinger
SDGR
$1.94B
| $121K | ﹤0.01% |
6,000
-4,000
| -40% | -$91.3K |
2022 Q1
13 quarters
|
|
1567
Enterprise Financial Services Corp
EFSC
$2.15B
| $120K | ﹤0.01% |
2,182
+1,123
| +106% | +$58.6K |
2013 Q2
48 quarters
|
|
1568
Vishay Intertechnology
VSH
$4.91B
| $116K | ﹤0.01% |
7,296
-200,208
| -96% | -$2.78M |
2013 Q2
48 quarters
|
|
1569
Southern Missouri Bancorp
SMBC
$776M
| $113K | ﹤0.01% |
2,065
| – | – |
2017 Q1
33 quarters
|
|
1570
Archer Daniels Midland
ADM
$38.8B
| $110K | ﹤0.01% |
2,091
-8,531
| -80% | -$415K |
2013 Q2
48 quarters
|
|
1571
Beacon Financial Corp
BBT
$2.29B
| $110K | ﹤0.01% |
4,395
| – | – |
2014 Q2
44 quarters
|
|
|
TWO
1572
DELISTED
Two Harbors Investment
TWO
| $109K | ﹤0.01% |
10,090
-355
| -3% | -$4K |
2025 Q1
1 quarter
|
|
1573
DaVita
DVA
$11.6B
| $109K | ﹤0.01% |
762
-139
| -15% | -$19.7K |
2013 Q2
48 quarters
|
|
1574
Northeast Bank
NBN
$1.09B
| $108K | ﹤0.01% |
1,216
-82
| -6% | -$7K |
2017 Q4
30 quarters
|
|
1575
Hershey
HSY
$32.9B
| $107K | ﹤0.01% |
644
-5
| -0.8% | -$824 |
2013 Q2
48 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.